News search

E.g., 24/09/2022
E.g., 24/09/2022
About the CNIC
19 Sep 2022

CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference

Pablo García Pavía and Luis Escobar
Research
12 Sep 2022

The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease


Los adolescentes que duermen menos de 8 horas tienen más probabilidades de tener sobrepeso u obesidad
Research
29 Aug 2022

Excess weight and metabolic syndrome are associated with cardiovascular disease, suggesting that health promotion programs in schools should teach good sleep habits

Fernando de Frutos y el Dr. Pablo García Pavía.
Research
29 Aug 2022

The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease

Valentín Fuster
Research
26 Aug 2022

The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

About the CNIC
23 Aug 2022

The finding provides a basis for mitigating the loss of muscle regenerative capacity in elderly people

Imagen de histología que muestra la comparación del tamaño del corazón de un ratón normal (izquierda) y un ratón deficiente para la proteína MKK6 (derecha).
Research
9 Aug 2022

A new study published in eLife shows that inhibition of p38γ/δ is a potential therapeutic strategy for the treatment of hypertrophic cardiomyopathy, but that this strategy has yet to be explored because of the lack of specific inhibitors for these p38 family members

La Dra. Amelia Escolano
About the CNIC
9 Aug 2022

Dr. Amelia Escolano runs her own group in Philadelphia (USA) where she is an Assistant Professor at the Wistar Institute's Center for Vaccines and Immunotherapy

Participants who followed the TANSNIP-PESA program (orange line) showed an improvement in lifestyle measures and cardiovascular health compared with participants in the control group (who did not participate in the intervention; blue line). The Y-axis shows changes in the Fuster -BEWAT lifestyle and cardiovascular risk score with respect to the baseline value.
Research
26 Jul 2022

Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals

Dr. Pablo García-Pavía y Dr. Jesús Gonzalez Mirelis, codirectores del trabajo.
Research
22 Jul 2022

Genetic screening combined with the detection of fibrosis identifies patients at risk of malignant arrhythmias or developing heart failure with severe complications